Q32 Bio (QTTB) Net Equity Issued and Repurchased (2017 - 2026)
Q32 Bio's (QTTB) quarterly Net Equity Issued and Repurchased came in at $10.4 million in Q1 2026, down 75.33% quarter-over-quarter from $42.0 million in Q1 2024.
Q32 Bio (QTTB) Net Equity Issued and Repurchased (2017 - 2026) Analysis & Trends
Q32 Bio's Net Equity Issued and Repurchased history runs 6 years deep, the most recent figure standing at $10.4 million for Q1 2026.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $10.4 million in Q1 2026; TTM through Mar 2026 was $10.4 million, a N/A change from a year earlier, with the FY2024 full-year figure at $42.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased eased to $10.4 million in Q1 2026 per QTTB's latest filing, from $42.0 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $42.0 million in Q1 2024 and bottomed at $10.4 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 141.90 Mn |
| 10 | Q32 Bio | 215.94 Mn | 165.19 Mn | - | 10.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.36 Mn |
| Mar 31, 2026 | 10.36 Mn |
| Mar 31, 2024 | 42.00 Mn |
| Mar 31, 2024 | 42.00 Mn |
| Jun 30, 2021 | 48.29 Mn |
| Jun 30, 2021 | 48.29 Mn |
| Mar 31, 2021 | 1.45 Mn |
| Mar 31, 2021 | 1.45 Mn |
| Sep 30, 2019 | -28,000.00 |
| Sep 30, 2019 | -28,000.00 |
| Mar 31, 2018 | 69,263.00 |
| Mar 31, 2018 | 69,263.00 |
| Dec 31, 2017 | -488.00 |
| Dec 31, 2017 | -488.00 |
| Mar 31, 2017 | 20.48 Mn |
| Mar 31, 2017 | 20.48 Mn |